• Product Name3 - (benzyloxy) - 4-oxo-4h-pyran-2-carboxylic acid
  • CasNo. 518048-03-8
  • MFC16H19FN4O3
  • MW334.35
  • Purity
  • AppearanceWhite solid (powder)
  • Packing
  • Contact usInquiry

Product Details

CasNo: 518048-03-8

MF: C16H19FN4O3

Appearance: White solid (powder)

Top quality factory supply 518048-03-8 3 - (benzyloxy) - 4-oxo-4h-pyran-2-carboxylic acid at low price

  • Molecular Formula:C16H19FN4O3
  • Molecular Weight:334.35
  • Appearance/Colour:White solid (powder) 
  • Melting Point:105-107°C 
  • Refractive Index:1.607 
  • Boiling Point:567.4 °C at 760 mmHg 
  • PKA:4.50±1.00(Predicted) 
  • Flash Point:311 °C 
  • PSA:110.24000 
  • Density:1.373 g/cm3 
  • LogP:1.84000 

2-(1-Amino-1-methylethyl)-N-(4-fluorobenzyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidine-4-carboxamide(Cas 518048-03-8) Usage

InChI:InChI=1/C16H19FN4O3/c1-16(2,18)15-20-11(12(22)14(24)21(15)3)13(23)19-8-9-4-6-10(17)7-5-9/h4-7,22H,8,18H2,1-3H3,(H,19,23)

518048-03-8 Relevant articles

A Facile Synthesis of Raltegravir Potassium—An HIV Integrase Inhibitor

Karumanchi, Kishore,Nangi, Gangadhara Bhima Shankar,Danda, Subba Reddy,Chavakula, Ramadas,Korupolu, Raghu Babu,Bonige, Kishore Babu

, p. 2683 - 2690 (2019)

A facile, cost-effective, and commercial...

A newfangled synthesis of integrase inhibitor drug substance raltegravir potassium

Rao, S. Venkat,Potluri, Vamsi Krishna,Potluri, Ramesh Babu

, p. 2618 - 2622 (2019/10/02)

Raltegravir sodium synthesis was achieve...

Preparation method of pyrimidinone amide type compound

-

Paragraph 0047; 0048; 0049, (2018/10/19)

The invention discloses a pyrimidinone a...

(Chloromethyl)dimethylchlorosilane-KF: A Two-Step Solution to the Selectivity Problem in the Methylation of a Pyrimidone Intermediate en Route to Raltegravir

Stathakis, Christos I.,Gkizis, Petros L.,Alexandraki, Elli S.,Trakossas, Sakellarios,Terzidis, Michael,Neokosmidis, Efstratios,Zacharis, Constantinos K.,Vasiliadou, Christina,Vastardi, Elli,Andreou, Thanos,Zitrou, Asteria,Varvogli, Anastasia-Aikaterini,Koftis, Theocharis V.

, p. 1413 - 1418 (2017/09/22)

The present work describes a two-step pr...

518048-03-8 Process route

{1-[4-(4-fluoro-benzylcarbamoyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydro-pyrimidin-2-yl]-1-methyl-ethyl}carbamic acid benzyl ester
518048-02-7

{1-[4-(4-fluoro-benzylcarbamoyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydro-pyrimidin-2-yl]-1-methyl-ethyl}carbamic acid benzyl ester

2-(1-amino-1-methyl-ethyl)-N-[(4-fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-6-oxo-4-pyrimidinecarboxamide
518048-03-8

2-(1-amino-1-methyl-ethyl)-N-[(4-fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-6-oxo-4-pyrimidinecarboxamide

Conditions
Conditions Yield
With palladium 10% on activated carbon; hydrogen; In methanol;
100%
{1-[4-(4-fluoro-benzylcarbamoyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydro-pyrimidin-2-yl]-1-methyl-ethyl}carbamic acid benzyl ester; With methanesulfonic acid; 5%-palladium/activated carbon; hydrogen; In methanol; at 12 ℃; under 775.743 Torr; Large scale reaction;
With sodium hydroxide; In methanol; water; at 5 - 23 ℃; pH=8;
99%
{1-[4-(4-fluoro-benzylcarbamoyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydro-pyrimidin-2-yl]-1-methyl-ethyl}carbamic acid benzyl ester; With formic acid; potassium formate; palladium 10% on activated carbon; In methanol; water; at 50 ℃; for 2.5h;
With sodium hydroxide; In methanol; water; at 5 - 20 ℃; for 21h;
98%
With methanesulfonic acid; hydrogen; 5%-palladium/activated carbon; In methanol; at 20 - 50 ℃; for 3 - 4h; under 2828.7 Torr;
96%
With methanesulfonic acid; hydrogen; 5% palladium over charcoal; In methanol; at 20 - 50 ℃; for 3 - 4h; under 2828.7 Torr;
96%
With methanesulfonic acid; hydrogen; 5% palladium over charcoal; In methanol; at 50 ℃; for 3 - 4h; under 2068.65 Torr;
96%
With methanesulfonic acid; hydrogen; 5% palladium over charcoal; In methanol; at 20 - 50 ℃; for 3 - 4h; under 2828.7 Torr;
96%
{1-[4-(4-fluoro-benzylcarbamoyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydro-pyrimidin-2-yl]-1-methyl-ethyl}carbamic acid benzyl ester; With methanesulfonic acid; water; hydrogen; 5% palladium over charcoal; In methanol; at 50 ℃; for 3 - 4h; under 2828.7 Torr;
With sodium hydroxide; In methanol; water; pH=7 - 8.0;
96%
With 5%-palladium/activated carbon; hydrogen; In methanol; at 25 ℃; under 6723.1 Torr;
91%
With hydrogen bromide; In water; at 28 - 62 ℃; for 2.5h;
With glycolic Acid; 5%-palladium/activated carbon; hydrogen; In methanol; under 6723.1 Torr; Reagent/catalyst;
65 g
With sodium hydroxide; In ethanol; butan-1-ol; Reagent/catalyst; Reflux;
3 g
N-[(4-fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-2-[1-methyl-1-[[(methoxy)carbonyl]amino]ethyl]-6-oxo-4-pyrimidine carboxamide

N-[(4-fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-2-[1-methyl-1-[[(methoxy)carbonyl]amino]ethyl]-6-oxo-4-pyrimidine carboxamide

2-(1-amino-1-methyl-ethyl)-N-[(4-fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-6-oxo-4-pyrimidinecarboxamide
518048-03-8

2-(1-amino-1-methyl-ethyl)-N-[(4-fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-6-oxo-4-pyrimidinecarboxamide

Conditions
Conditions Yield
With sodium hydroxide; In butan-1-ol; at 105 - 110 ℃; for 3h; Concentration; Solvent; Temperature; Time;
85%
With sodium hydroxide; In butan-1-ol; at 100 - 110 ℃; for 2h; Concentration; Temperature; Reagent/catalyst; Solvent;
79%

518048-03-8 Upstream products

  • 518048-02-7
    518048-02-7

    {1-[4-(4-fluoro-benzylcarbamoyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydro-pyrimidin-2-yl]-1-methyl-ethyl}carbamic acid benzyl ester

  • 888504-27-6
    888504-27-6

    2-(1-benzyloxycarbonylamino-1-methyl-ethyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydro-pyrimidine-4-carboxylic acid methyl ester

  • 140-75-0
    140-75-0

    para-fluorobenzylamine

  • 519028-33-2
    519028-33-2

    benzyl 2-(4-(4-fluorobenzylcarbamoyl)-5-hydroxy-6-oxo-1,6-dihydropyrimidin-2-yl)propan-2-ylcarbamate

518048-03-8 Downstream products

  • 518048-05-0
    518048-05-0

    raltegravir

  • 518048-04-9
    518048-04-9

    methyl {[1-(4-{[(4-fluorobenzyl)amino]carbonyl}-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)-1-methylethyl]amino}(oxo)acetate

  • 1064707-02-3
    1064707-02-3

    N-(4-fluorobenzyl)-5-hydroxy-1-methyl-2-(1-methyl-1-[(pyridin-2ylcarbonyl)amino]ethyl)-6-oxo-1,6-dihydropyrimidine-4-carboxamide

  • 1064707-06-7
    1064707-06-7

    N-(4-fluorobenzyl)-5-hydroxy-1-methyl-2-{1-methyl-1-[(1,3-thiazol-5-ylcarbonyl)amino]ethyl}-6-oxo-1,6-dihydropyrimidine-4-carboxamide

Relevant Products